title: [Cost-effectiveness analysis of treatment for end-stage renal disease].
abstract: OBJECTIVE
  End-stage renal disease (ESRD) requires costly life-sustaining therapy, either dialysis or kidney transplantation. The purpose of this study was to analyse and compare the cost-effectiveness of kidney transplantation and dialysis in Iceland.
  
  
  METHODS
  Costs and effectiveness were assessed using the clinical records of the Division of Nephrology patient registration and billing systems and at Landspitali University Hospital, information from the Icelandic Health Insurance on payments for kidney transplantation at Rigshospitalet in Copenhagen, and published studies on survival and quality of life among patients with ESRD. All costs are presented at the 2006 price level and discounting was done according to the lowest interest rate of the Icelandic Housing Finance Fund in that year.
  
  
  RESULTS
  The cost associated with live donor kidney transplantation was greater in Denmark than at LUH, ISK 6.758.101 and ISK 5.442.763, respectively. The cost per quality-adjusted life year gained by live donor kidney transplantation was approximately ISK 2.5 million compared to ISK 10.7 million for dialysis.
  
  
  CONCLUSIONS
  The cost of live donor kidney transplantation is within the range generally considered acceptable for life-sustaining therapies. The transplant surgery is less expensive in Iceland than in Denmark. Increasing the number of kidney transplants is cost-effective in light of the lower cost per life-year gained by kidney transplantation compared to dialysis.
authors.affiliation: Lanspítala Eiríksgötu 5, 105 Reykjavík, Iceland.
authors.forename: Tinna Laufey
authors.initials: TL
authors.lastname: Asgeirsdóttir
authors.forename: Gyda
authors.initials: G
authors.lastname: Asmundsdóttir
authors.forename: María
authors.initials: M
authors.lastname: Heimisdóttir
authors.forename: Eiríkur
authors.initials: E
authors.lastname: Jónsson
authors.forename: Runólfur
authors.initials: R
authors.lastname: Pálsson
mesh_terms: D003362:Cost-Benefit Analysis; D003718:Denmark / Q000453:epidemiology; D017048:Health Care Costs; D006801:Humans; D007055:Iceland / Q000453:epidemiology; D007676:Kidney Failure, Chronic / Q000191:economics* / Q000401:mortality / Q000628:therapy*; D016030:Kidney Transplantation / Q000191:economics*; D019520:Living Donors; D018803:Models, Economic; D010043:Outcome and Process Assessment, Health Care / Q000191:economics*; D011788:Quality of Life; D019057:Quality-Adjusted Life Years; D006435:Renal Dialysis / Q000191:economics*; D016896:Treatment Outcome